Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 22 of the 65 sources its claims cite were checked for support.
Abstract
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease (1,2). Although �-cell failure is the sine qua non for development of type 2 diabetes, skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before �-cell failure and overt hyperglycemia develops (3,4). Insulin resistance is defined as a reduced response of target tissues (compared with subjects with normal glucose tolerance [NGT] without a family history of diabetes), such as the skeletal muscle, liver, and adipocytes, to
Overview
CoChat Summary
TL;DR
This review argues that skeletal muscle insulin resistance—especially impaired glycogen synthesis—is the initiating/primary defect in most type 2 diabetes, preceding β-cell failure and overt hyperglycemia. It concludes that overt diabetes requires β-cell failure to supervene, while muscle insulin resistance is already evident in normal glucose-tolerant high-risk relatives and prospective populations.
Key findings
- Skeletal muscle is the predominant site of insulin-mediated postprandial glucose uptake: under euglycemic hyperinsulinemia, ∼80% of glucose uptake occurs in skeletal muscle; leg muscle glucose uptake plateaus at ∼10 mg/kg leg weight per minute after 60 min, and in lean type 2 diabetic subjects it is reduced by ∼50% during the last hour of the insulin clamp.
- In lean NGT offspring of two type 2 diabetic parents, a two-step euglycemic clamp (20 and 40 mU/m² per min; plasma insulin ∼40 and ∼80 μU/ml) showed glucose uptake decreased by 33% and 43%, respectively; the impairment was accounted for entirely by reduced nonoxidative glucose metabolism/glycogen synthesis, with no defect in insulin suppression of hepatic glucose production.
- Prospective Pima Indian data showed both progressors and nonprogressors had a further 11–14% reduction in insulin sensitivity; nonprogressors increased insulin secretion by 30%, whereas progression to type 2 diabetes was associated with a 78% decline in the acute insulin response to intravenous glucose.
- Hyperinsulinemia itself worsens muscle insulin resistance: a 72 pmol/l (11 μU/ml) increase in plasma insulin for 72–96 h reduced insulin-stimulated glucose disposal by 30–40%, entirely via impaired nonoxidative glucose disposal; in rats, 7-day hyperinsulinemia reduced total-body glucose uptake, storage, and glycolysis by 39%, 62%, and 26%. Mitochondrial ATP production increased by 90% in NGT subjects without family history but only 5% in insulin-resistant offspring.
Methods
- Narrative review/symposium article; no primary study design or new sample. It synthesizes human studies using the euglycemic insulin clamp (described as the gold standard), indirect calorimetry, muscle biopsy, femoral/forearm catheterization, PET, NMR spectroscopy, OGTT, and prospective follow-up.
- Populations discussed include lean NGT first-degree relatives/offspring of two type 2 diabetic parents, Mexican Americans, Pima Indians, Caucasians in San Antonio, and type 2 diabetic subjects. Main analysis is qualitative synthesis of cited evidence.
Limitations
- Stated: by the time hyperglycemia is manifest, multiple abnormalities (elevated glucose, FFA, and cytokines) coexist, making it extremely difficult to separate each defect’s contribution; at initial presentation it is not possible to define which defect came first.
- Stated: it is unclear whether mitochondrial dysfunction leads to increased intramyocellular lipid and insulin resistance or increased muscle lipid leads to mitochondrial dysfunction and insulin resistance (“which is the cart and which is the horse”).
- Evident: as a narrative review, it lacks systematic search, formal quality assessment, or meta-analysis; conclusions depend on selected cited studies, and several figures are in an online appendix rather than the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 22 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In type 2 diabetes, impaired glycogen synthesis secondary to reduced glycogen synthase activity is the earliest detectable metabolic defect ( 39 – 41 ).”
What the sources say
- Not matchedcites [39] DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes, Diabetes Rev
We searched by its title and found no matching paper.
- Partly supportedcites [40] Bogardus, 1984, Correlation between muscle glycogen synthase activity and in vivo insulin action in man, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a correlation between muscle glycogen synthase activity and insulin-mediated glucose storage in glucose-tolerant and diabetic subjects. It hypothesizes a link between reduced enzyme activity and impaired glucose handling, but does not establish that one causes the other or that impaired glycogen synthesis is the earliest detectable metabolic defect in type 2 diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Shulman, 1990, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med source
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
What the sources say
- Partly supportedcites [26] Krook, 2000, Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes sourceExperimental — accuracy not yet measured
The paper’s introduction identifies IRS-1 and PI 3-kinase as components of insulin signaling involved in skeletal-muscle glucose transport. Its study summary says reduced PI 3-kinase activity may partly account for reduced insulin-stimulated glucose transport, while additional defects contribute. The cited passages do not establish a role for Akt or show that integrity of the entire pathway is essential for normal uptake. (LLM, conf=0.88)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
What the sources say
- Not checked — no full text of the sourcecites [28] Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes source
- Not checked — no full text of the sourcecites [29] Ferrannini, 2003, Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [30] Kashyap, 2004, Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes, Am J Physiol Endocrinol Metab source
- Partly supportedcites [31] Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, J Clin Invest sourceExperimental — accuracy not yet measured
The Subjects section says the participants were nonobese, had normal oral glucose tolerance, and had at least one parent with NIDDM—not necessarily two. The Discussion reports skeletal-muscle insulin resistance but also considerable overlap with controls; it does not establish moderate-to-severe resistance in offspring of two affected parents. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [32] Gulli, 1992, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents, Diabetes source
- Not checked — no full text of the sourcecites [33] Tripathy, 2003, Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband, Am J Physiol source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In lean insulin-resistant NGT offspring of type 2 diabetic parents, increased serine phosphorylation of IRS-1 in skeletal muscle has been documented in association with impaired activation of Akt ( 57 ) (Fig. A11).”
What the sources say
- Supportedcites [57] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest source
The Introduction describes the offspring as young, lean, normoglycemic, and insulin-resistant. The Results report increased IRS-1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation in the offspring, and the Discussion explicitly describes these findings as associated. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
What the sources say
- Not checked — no full text of the sourcecites [59] Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science source
- Partly supportedcites [60] Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion says elevated free fatty acids may impair insulin’s metabolic action and notes protein kinase C activation in skeletal muscle. It does not say that diacylglycerol, long-chain fatty acyl CoAs, or ceramides cause IRS-1 serine phosphorylation and thereby produce skeletal-muscle insulin resistance; its serine-phosphorylation discussion concerns the insulin receptor instead. Page numbers are unavailable in our copy. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims · 6 with their cited sources checked
Create a free account to see all 48 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various epidemiological and experimental studies have shown that muscle weakness, decreased muscle mass, reduced activation of glycogen synthase, and alterations in the numbers of glycolytic skeletal muscle fibers are related to, and may precede, insulin resistance, glucose intolerance, and T2D [332,333].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [333]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurodegenerative disorders (Cunnane et al., 2011; Yao et al., 2011), and cancer (Currie et al., 2013; Tennant et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as DeFronzo and Tripathy, 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
From Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle is the main tissue responsible for insulin-stimulated glucose disposal and an impaired uptake is common in obesity and has substantial impact on whole-body glucose turnover.8,9”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“RESEARCH DESIGN AND METHODS — The euglycemic insulin clamp technique (5) is considered to be the gold standard for measuring insulin action in vivo.”
BackgroundSelf-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“70) with insulin sensitivity measured with the euglycemic insulin clamp (9).”
MethodSelf-citationKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“This results in activation of downstream protein kinase B (also called Akt) and phosphorylation of Akt substrate 160 (AS160), which facilitates the translocation of GLUT4 to the sarcolemma and subsequent entry of glucose into the cell (25).”
BackgroundHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 7×
“Because the majority of type 2 diabetic subjects are obese, they also have daylong elevation of the plasma free fatty acid (FFA) concentration and increased circulating levels of inflammatory cytokines (1,2).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 2
- Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 · DOI · Paper page
- Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/jci25151 · DOI · Paper page
Cited by
Items 701–800 of 2,099
Wolff, C. A., Lawrence, M. M., Porter, H. L., Zhang, Q., Reid, J. J., Laurin, J. L., Musci, R. V., Linden, M. A., Peelor, F. F., Wren, J. D., et al. (2020) · GeroScience · doi:10.1007/s11357-020-00243-8 · Cited by 27
“Skeletal muscle is the largest organ in the body, contributing to locomotion as well as playing an integral role in systemic metabolic health by regulating energy balance [60], insulin sensitivity [9], and immune function [45] to name a few.”
BackgroundToledo, F. G. S., Miller, R. G., Helbling, N. L., Zhang, Y., & DeLany, J. P. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14333 · Cited by 27
“combined actions of insulin to inhibit hepatic glucose output and stimulate glucose disposal, most of which is attributable to skeletal muscle under high-insulin conditions.(16) When these independent components were investigated, we found that HCQ improved glucose metabolism predominantly by augmenting insulin sensit…”
BackgroundMethodMengeste, A. M., Lund, J., Katare, P. B., Ghobadi, R., Bakke, H. G., Lunde, P., Eide, L., Mahony, G. O., Göpel, S., Peng, X., et al. (2021) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2021.100060 · Cited by 25
“…skeletal muscle is the largest insulin-sensitive organ, accounting for ~80% of insulin-stimulated glucose disposal (R. A. DeFronzo, 2004; Ralph A. DeFronzo and Tripathy, 2009), hyperglycaemia due to the reduced ability of insulin to increase glucose uptake is a key feature implicated in the…”
BackgroundFat-to-muscle Ratio: A New Indicator for Coronary Artery Disease in Healthy Adults
Eun, Y., Lee, S. N., Song, S.-W., Kim, H.-N., Kim, S., Lee, Y.-A., Kang, S. G., Rho, J.-S., & Yoo, K. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.62871 · Cited by 26
“In addition, increased plasma fatty acids promote the accumulation of fat in the muscles, leading to abnormalities in mitochondrial function and resulting in muscle insulin resistance [20].”
BackgroundUnacylated ghrelin restores insulin and autophagic signaling in skeletal muscle of diabetic mice
Tam, B. T., Pei, X. M., Yung, B. Y., Yip, S. P., Chan, L., Wong, S. C. C., & Siu, P. M. (2015) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-015-1721-5 · Cited by 27
“resistance, in which muscle cells do not respond adequately to normal insulin concentration and is a key feature of type 2 diabetes [14].”
Insulin receptor‐insulin interaction kinetics using multiplex surface plasmon resonance
Subramanian, K., Fee, C. J., Fredericks, R., Stubbs, R. S., & Hayes, M. T. (2013) · Journal of Molecular Recognition · doi:10.1002/jmr.2307 · Cited by 23
“Insulin resistance is one of the major factors contributing to type 2 diabetes (DeFronzo and Tripathy, 2009), which is defined as the failure of insulin targets to respond adequately to insulin (Pittas et al., 2004).”
BackgroundTreatment options for diabetes: Potential role of stem cells
Stanekzai, J., Isenović, E. R., & Mousa, S. A. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.010 · Cited by 28
“[9] DeFronzo RA, Tripathy D.”
BackgroundTurner, K., Keogh, J. B., Meikle, P. J., & Clifton, P. M. (2017) · Nutrients · doi:10.3390/nu9080886 · Cited by 26
Burghardt, K. J., Seyoum, B., Dass, S. E., Sanders, E., Mallisho, A., & Yi, Z. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2097 · Cited by 26
Adhesion G-protein coupled receptors: Implications for metabolic function
Olaniru, O. E., & Persaud, S. J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.012 · Cited by 24
ApoAI-derived peptide increases glucose tolerance and prevents formation of atherosclerosis in mice
Edmunds, S. J., Liébana-García, R., Nilsson, O., Domingo‐Espín, J., Grönberg, C., Stenkula, K. G., & Lagerstedt, J. O. (2019) · Diabetologia · doi:10.1007/s00125-019-4877-2 · Cited by 24
“As about 80% of blood glucose in the postprandial state is disposed in skeletal muscle in healthy individuals [1], a lack of this function results in hyperglycaemia and increased risk of muscle fatigue.”
BackgroundMammalian Target of Rapamycin at the Crossroad Between Alzheimer’s Disease and Diabetes
Liang, H., Nie, J., Skike, C. E. V., Valentine, J. M., & Orr, M. E. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3540-2_10 · Cited by 27
Yuan, Q., Zhan, B., Du, ., Chang, R., Li, T.-G., & Mao, X. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103435 · Cited by 27
A muscle-specific UBE2O/AMPKα2 axis promotes insulin resistance and metabolic syndrome in obesity
Vila, I. K., Park, M. K., Setijono, S. R., Yao, Y., Kim, H., Badin, P.-M., Choi, S., Narkar, V. A., Choi, S., Chung, J., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.128269 · Cited by 28
“Although skeletal muscle primarily accounts for insulin-stimulated glucose disposal (6, 7), the mechanism underlying insulin resistance in muscle is poorly understood.”
BackgroundPlasma carnosine, but not muscle carnosine, attenuates high-fat diet-induced metabolic stress
Stegen, S., Stegen, B., Aldini, G., Altomare, A., Cannizzaro, L., Orioli, M., Gerlo, S., Deldicque, L., Ramaekers, M., Hespel, P., et al. (2015) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2015-0042 · Cited by 29
Skeletal muscle performance in metabolic disease: Microvascular or mitochondrial limitation or both?
Frisbee, J. C., Lewis, M. T., & Wiseman, R. W. (2018) · Microcirculation · doi:10.1111/micc.12517 · Cited by 24
Lee, S., Choi, S., Lee, H. B., Song, M., Kim, Y. H., Jeong, J. Y., KANG, Y. Y., Kim, H. J., Kim, T. H., Jeon, J. Y., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.601448 · Cited by 25
“Therefore, any abnormality in glucose metabolism in muscle tissue may induce lipotoxicity, resulting in systemic lipid accumulation and insulin resistance (Petersen et al., 2007; Petersen and Shulman, 2002; DeFronzo and Tripathy, 2009).”
BackgroundJun, J. E., Choi, M. S., Park, S. W., Kim, G., Jin, S., Kim, K., Hwang, Y., Ahn, K. J., Chung, H. Y., Jeong, I., et al. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.04.002 · Cited by 25
Xiang, C., Zhang, Y., Chen, Q., Sun, A., Peng, Y., Zhang, G., Zhou, D., Xie, Y., Hou, X., Zheng, F., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16698 · Cited by 26
Postprandial Dysmetabolism and the Heart
Garber, A. J. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.004 · Cited by 24
Hamilton, D. L., Findlay, J. A., Montagut, G., Meakin, P. J., Bestow, D., Jalicy, S. M., & Ashford, M. L. J. (2014) · Diabetologia · doi:10.1007/s00125-014-3269-x · Cited by 20
“However, the first detectable defect in individuals predisposed to type 2 diabetes is altered responsiveness of skeletal muscle to insulin [1, 2], the principal site for insulinstimulated glucose disposal [3].”
BackgroundAguer, C., Pasqua, M., Thrush, A. B., Moffat, C., McBurney, M. W., Jardine, K. E., Zhang, R., Beauchamp, B., Dent, R., McPherson, R., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.008 · Cited by 25
Wu, H., Sui, C., Xu, H., Xia, F., Zhai, H., Zhang, H., Weng, P., Han, B., Du, S., & Lu, Y. (2014) · Journal of Diabetes Research · doi:10.1155/2014/524517 · Cited by 25
“Skeletal muscle insulin resistance is the primary defect in diabetes [25], preceding the failure of beta cell function and overt hyperglycemia [26, 27].”
BackgroundPEDF attenuates insulin-dependent molecular pathways of glucose homeostasis in skeletal myocytes
Carnagarin, R., Dharmarajan, A., & Dass, C. R. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.12.010 · Cited by 23
Circulating linoleic acid and alpha-linolenic acid and glucose metabolism: the Hoorn Study
Cabout, M., Alssema, M., Nijpels, G., Stehouwer, C. D. A., Zock, P. L., Brouwer, I. A., Elshorbagy, A. K., Refsum, H., & Dekker, J. M. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1261-6 · Cited by 27
“This is plausible given that FPG and PLG are the primary markers of insulin sensitivity in the liver and the peripheral tissues, respectively [42].”
BackgroundChakraborty, S., Bhattacharyya, R., & Banerjee, D. (2017) · Advances in clinical chemistry · doi:10.1016/bs.acc.2016.11.004 · Cited by 25
Takeuchi, M., Imano, H., Muraki, I., Shimizu, Y., Hayama‐Terada, M., Kitamura, A., Okada, T., Kiyama, M., & Iso, H. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000492 · Cited by 26
“Reduced glucose uptake in skeletal muscle is considered to be a primary pathogenesis for insulin resistance and type 2 diabetes mellitus, that is evident decades before overt hyperglycemia develops.(6) We predicted the reduction of skeletal muscle to be associated with increased insulin resistance and risk of type 2 d…”
BackgroundWahjuningsih, S. B., Haslina, H., & Marsono, M. (2018) · Materia Socio Medica · doi:10.5455/msm.2018.30.232-239 · Cited by 31
“High HOMA-IR indicates lower insulin sensitivity due to a decrease insulin response in target tissue (32).”
BackgroundCharacterization of the Therapeutic Profile of Albiflorin for the Metabolic Syndrome
Zhou, X., Fouda, S., Zeng, X., Li, D., Zhang, K., Xu, J., & Ye, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01151 · Cited by 24
Kang, B., & Chiang, B. (2019) · Phytotherapy Research · doi:10.1002/ptr.6561 · Cited by 24
“…(DeFronzo, Gunnarsson, Bjorkman, Olsson, & Wahren, 1985) and capability of absorbing 80% glucose into cells through glycogen synthesis and glucose metabolism (Kahn, Hull, & Utzschneider, 2006), is recognized as the primary tissue in the etiology of insulin resistance (DeFronzo & Tripathy, 2009).”
BackgroundRussell, S. J., & Schneider, M. F. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013634 · Cited by 25
“Indeed, skeletal muscle insulin insensitivity is implicated as a major marker for the onset of type 2 diabetes (1).”
BackgroundThe impact of dietary interventions on cardiometabolic health
Gjermeni, E., Fiebiger, R., Bundalian, L., Garten, A., Schöneberg, T., Duc, D. L., & Blüher, M. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02766-w · Cited by 29
“Insulin resistance in skeletal muscle can emerge decades before the onset of β-cell failure [11, 20–22].”
IGFBP5 suppresses oleate‐induced intramyocellular lipids deposition and enhances insulin signaling
Xiang, A., Chu, G., Zhu, Y., Ma, G., Yang, G., & Sun, S. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28174 · Cited by 21
“Skeletal muscle is the main site of IR (DeFronzo & Tripathy, 2009).”
BackgroundAstrocyte Clocks and Glucose Homeostasis
Barca‐Mayo, O., & López, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.662017 · Cited by 23
Kim, G., Song, B. K., Kim, J. W., Lefferts, E. C., Brellenthin, A. G., Lee, D.-C., Kim, Y., Kim, M. K., Choi, B. Y., & Kim, Y. S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256550 · Cited by 24
“Skeletal muscle is a major organ for glucose uptake [3], and indeed, lower muscle mass is associated with a greater risk of developing T2DM [4].”
BackgroundLuo, J., Yao, W., Zhang, T., Ge, H., & Zhang, D. (2021) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2021.110678 · Cited by 21
Archer, E., & Lavie, C. J. (2022) · Nutrients · doi:10.3390/nu14112286 · Cited by 28
The genetics of bipolar disorder with obesity and type 2 diabetes
Miola, A., Filippis, E. D., Veldić, M., Ho, A. M., Winham, S. J., Mendoza, M., Romo‐Nava, F., Núñez, N. A., Gardea‐Resendez, M., Prieto, M. L., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.06.084 · Cited by 29
Nieblas, B., Pérez-Treviño, P., & García, N. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.959844 · Cited by 29
“Therefore, IR in SM importantly impacts blood glucose levels with consequences of altered insulin signaling for the whole body and is considered an important metabolic alteration related to obesity, which precedes T2D development (DeFronzo and Tripathy, 2009; Petersen and Shulman, 2018).”
BackgroundWhytock, K. L., Pino, M. F., Sun, Y., Yu, G., de Carvalho, F. G., Yeo, R. X., Vega, R. B., Parmar, G., Divoux, A., Kapoor, N., et al. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00143.2023 · Cited by 29
Exercise as an intervention to improve metabolic outcomes after intrauterine growth restriction
Gatford, K. L., Kaur, G., Falcão‐Tebas, F., Wadley, G. D., Wlodek, M. E., Laker, R. C., Ebeling, P. R., & McConell, G. K. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00456.2013 · Cited by 23
“Over 80% of 163 whole body insulin-stimulated glucose uptake occurs in skeletal muscle (27) and defects in 164”
BackgroundUrocortin 3 activates AMPK and AKT pathways and enhances glucose disposal in rat skeletal muscle
Roustit, M. M., Vaughan, J. M., Jamieson, P. M., & Cleasby, M. E. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0181 · Cited by 25
“Impaired insulin-stimulated glucose disposal into skeletal muscle is a major component of the insulin resistance (IR) that develops in advance of type 2 diabetes (T2D) (DeFronzo & Tripathy 2009).”
BackgroundInfluentialIs Acetylation a Metabolic Rheostat that Regulates Skeletal Muscle Insulin Action?
LaBarge, S. A., Migdal, C., & Schenk, S. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0020 · Cited by 22
“In skeletal muscle, a post-prandial increase in circulating insulin normally results in increased glucose uptake into the myocyte, of which approximately one-third enters glycolysis and twothirds is converted to glycogen (DeFronzo and Tripathy, 2009).”
BackgroundKitamura, K., Takamura, Y., Iwamoto, T., Nomura, M., Iwasaki, H., Ohdera, M., Murakoshi, M., Sugiyama, K., Matsuyama, K., Manabe, Y., et al. (2016) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2016.1246173 · Cited by 23
Yuan, H., Wang, T., Niu, Y., Liu, X., & Fu, L. (2016) · FEBS Letters · doi:10.1002/1873-3468.12516 · Cited by 23
“As the predominant tissue for insulin-stimulated glucose and lipid disposal, skeletal muscle is crucial for the development of whole body IR [1].”
Sleep apnea: An overlooked cause of lipotoxicity?
Gu, C., Younas, H., & Jun, J. C. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.09.007 · Cited by 23
“Skeletal muscle accounts for at least 75% of insulin-mediated glucose disposal [83], and is the most studied site of fatty acid-induced IR.”
BackgroundGhrelin Signaling in Immunometabolism and Inflamm-Aging
Fang, C., Xu, H., Guo, S., Mertens‐Talcott, S. U., & Sun, Y. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1286-1_9 · Cited by 23
UCHL1 regulates muscle fibers and mTORC1 activity in skeletal muscle
Gao, H., Freeling, J., Wu, P., Liang, A. P., Wang, X., & Li, Y. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116699 · Cited by 25
“Not only responsible for the body locomotion and posture, skeletal muscle is also a critical determinant of metabolism and energy homeostasis in physiological [1, 2] and pathophysiological conditions [3].”
BackgroundSun, Y., Yang, Z.-X., Ren, F., & Fang, B. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.04.186 · Cited by 25
FOXO1 Content Is Reduced in Cystic Fibrosis and Increases with IGF-I Treatment
Smerieri, A., Montanini, L., Maiuri, L., Bernasconi, S., & Street, M. E. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151018000 · Cited by 23
“A reduction in glucose uptake by the skeletal muscle is recognized to date as one of the principal mechanisms of insulin resistance, and intramyocellular lipid accumulation is thought to be one of the mechanisms involved [28,29].”
BackgroundVerbrugge, S. A. J., Alhusen, J. A., Kempin, S., Pillon, N. J., Rozman, J., Wackerhage, H., & Kleinert, M. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30179 · Cited by 21
“Chronic skeletal muscle insulin resistance, therefore, strains the β‐cells of the pancreas and is considered a key risk factor for developing type 2 diabetes mellitus (T2DM).(4) Exercise increases glucose uptake into skeletal muscle of healthy and diabetic individuals.”
BackgroundComparison of intramyocellular lipid metabolism in patients with diabetes and male athletes
Mezincescu, A. M., Rudd, A. E., Cheyne, L., Horgan, G. W., Philip, S., Cameron, D., van Loon, L. J. C., Whitfield, P. D., Gribbin, R., Hu, M. K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47843-y · Cited by 24
“The lipid mass may be estimated fromthe weighted sum of the lipid signals with weighting factors 13 accounting for the mass for a =CH-group (Lip52 and Lip53), 14 for -CH 2 - (Lip13 and Lip21) and 15 for the -CH 3 group (Lip09) .”
BackgroundOkuma, H., & Tsuchiya, K. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108699 · Cited by 24
Cordeiro, A. V., Silva, V. R. R., Pauli, J. R., da Silva, A. S. R., Cintra, D. E., de Moura, L. P., & Ropelle, E. R. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27870 · Cited by 25
Effects of exercise training on type 2-diabetes: the role of Meteorinlike protein
Saeidi, A., Tayebi, S. M., Khosravi, A., Malekian, F., Khodamoradi, A., Sellami, M., Abderrahman, A. B., & Zouhal, H. (2019) · Health Promotion Perspectives · doi:10.15171/hpp.2019.12 · Cited by 26
Migliaccio, V., Sica, R., Gregorio, I. D., Putti, R., & Lionetti, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123110 · Cited by 22
Qureshi, A. S., Ghaffor, J., Usman, M., Ehsan, N., Umar, Z., & Sarfraz, A. (2019) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-019-00457-4 · Cited by 31
UCHL1 regulates oxidative activity in skeletal muscle
Gao, H., Antony, R. M., Srinivasan, R., Wu, P., Wang, X., & Li, Y. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241716 · Cited by 21
“Skeletal muscle is the most abundant tissue in the body, accounting for over 40% of total body mass and playing a critical role in metabolism and energy homeostasis in physiological [1, 2] and pathophysiological conditions [3].”
BackgroundRecent Advances in In-Vitro Assays for Type 2 Diabetes Mellitus: An Overview
Vhora, N., Naskar, U., Hiray, A. R., Kate, A. S., & Jain, A. K. (2020) · The Review of Diabetic Studies · doi:10.1900/rds.2020.16.13 · Cited by 25
Huwatibieke, B., Yin, W., Liu, L., Jin, Y., Xiang, X., Han, J., Zhang, W., & Li, Y. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.638352 · Cited by 21
Langer, H. T., West, D. W. D., Senden, J. M., Spuler, S., van Loon, L. J. C., & Baar, K. (2022) · Scientific Reports · doi:10.1038/s41598-022-11621-x · Cited by 21
Huang, Y., Chen, W., Chen, M., Shia, B., & Wu, S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11112992 · Cited by 27
Luong, T. V., Pedersen, M. G. B., Abild, C. B., Lauritsen, K. M., Kjærulff, M. L. G., Møller, N., Gormsen, L. C., & Søndergaard, E. (2024) · Diabetes · doi:10.2337/db24-0162 · Cited by 25
Zhang, X., Gao, L., Liu, Z.-P., & Chen, L. (2015) · BMC Bioinformatics · doi:10.1186/s12859-015-0519-y · Cited by 22
Bi, Y., Wu, W., Shi, J., Liang, H., Yin, W., Chen, Y., Tang, S., Cao, S., Cai, M., Shen, S., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3136-1 · Cited by 24
“Although skeletal muscle is not thought to be as lipogenic as the liver, elevated skeletal muscle lipogenesis has been associated with insulin resistance and the development of type 2 diabetes [29, 30].”
BackgroundMaki, K. C., Lawless, A. L., Kelley, K., Dicklin, M. R., Schild, A. L., & Rains, T. M. (2011) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2011.06.005 · Cited by 21
“Insulin resistance is a central pathophysiologic factor in the development of type 2 diabetes mellitus [8].”
BackgroundBadin, P.-M., Vila, I. K., Sopariwala, D. H., Yadav, V., Lorca, S., Louche, K., Kim, E. R., Tong, Q., Song, M. S., Moro, C., et al. (2016) · Scientific Reports · doi:10.1038/srep26442 · Cited by 22
Histone deacetylase inhibition regulates miR-449a levels in skeletal muscle cells
Poddar, S., Kesharwani, D., & Datta, M. (2016) · Epigenetics · doi:10.1080/15592294.2016.1188247 · Cited by 23
Agostinis‐Sobrinho, C., Ramírez‐Vélez, R., García‐Hermoso, A., Moreira, C. M. M., Lopes, L., Oliveira‐Santos, J., Abreu, S., Mota, J. A. P. S., & Santos, R. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12607 · Cited by 24
“peripheral tissues, such as the adipocytes, liver, and skeletal muscle, to normal levels of insulin.(1) The skeletal muscle is the predominant site of insulin-mediated glucose uptake in the postprandial state,(1) and”
BackgroundAngelini, G., Salinari, S., BERTUZZI, A., Iaconelli, A., & Mingrone, G. (2018) · Communications Biology · doi:10.1038/s42003-018-0069-8 · Cited by 22
François, M. E., Gilbertson, N. M., Eichner, N. Z. M., Heiston, E. M., Fabris, C., Breton, M. D., Mehaffey, J. H., Hassinger, T. E., Hallowell, P. T., & Malin, S. K. (2018) · Nutrients · doi:10.3390/nu10060717 · Cited by 23
Archer, E., Pavela, G., McDonald, S. M., Lavie, C. J., & Hill, J. O. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01053 · Cited by 24
Zhao, M., Shen, L., Ouyang, Z., Li, M., Deng, G., Yang, C., Zheng, W., Kong, L., Wu, X., Wu, X., et al. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz050 · Cited by 21
“Our results highlight the potential importance of hnRNP A1 in the insulin resistance associated with T2D.”
InfluentialQin, P., Lou, Y., Cao, L., Shi, J. C., Tian, G., Liu, D., Zhou, Q., Guo, C., Li, Q., Zhao, Y., et al. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13038 · Cited by 20
Luo, J., Hou, Y., Xie, M., Ma, W., Shi, D., & Jiang, B. (2020) · Marine Drugs · doi:10.3390/md18050267 · Cited by 24
Maternal Nutrient Restriction and Skeletal Muscle Development: Consequences for Postnatal Health
Sandoval, C., Wu, G., Smith, S. B., Dunlap, K. A., & Satterfield, M. C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-45328-2_9 · Cited by 26
Hasegawa, Y., Takahashi, F., Hashimoto, Y., Munekawa, C., Hosomi, Y., Okamura, T., Okada, H., Senmaru, T., Nakanishi, N., Majima, S., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18084188 · Cited by 23
Hyder, K., Mohan, J., Varma, V., Ponnusankar, S., & Raja, D. (2021) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2021.101395 · Cited by 30
“Previous literatures have revealed that hyperinsulinemia and insulin resistance pave the way for impaired glucose tolerance followed by development of type 2 diabetes (DeFronzo and Tripathy, 2009).”
BackgroundThe Role of PGC-1α in the Development of Insulin Resistance in Skeletal Muscle - Revisited
Łukaszuk, B., Kurek, K., Mikłosz, A., Żendzian‐Piotrowska, M., & Chabowski, A. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000438584 · Cited by 23
Thymosin beta 4 ameliorates hyperglycemia and improves insulin resistance of KK Cg-Ay/J mouse
Zhu, J., Su, L., Ye, L., Lee, K., & Ma, J. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.12.009 · Cited by 21
“[29] DeFronzo RA, Tripathy D.”
BackgroundRomanos, M., Cordova, J. M. G., Villamarin, J. L., Zurita, J. D. P., & Acosta, A. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70659 · Cited by 35
Yuping, S., Jingli, S., Wu, Y., Chong, H., Junjie, Z., Yong-quan, S., & Zhimin, L. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20132975 · Cited by 23
“Because skeletal muscle is responsible for 70%–80% of insulin-stimulated glucose uptake, skeletal muscle insulin resistance is most likely a major determinant of type 2 diabetes.(1) Changes in genes and proteins involved in the inflammatory pathway that contribute to mitochondrial dysfunction were observed in insulin…”
BackgroundNunes, S., Viana, S., Preguiça, I., Alves, A., Fernandes, R., Teodoro, J. S., Matos, P., Figueirinha, A., Salgueiro, L., André, A., et al. (2021) · Nutrients · doi:10.3390/nu13124192 · Cited by 21
En, M., Kazantseva, A. Y., Dubinina, A., Denisova, E. I., Jakovleva, T., Balybina, N., Bgatova, N. P., Baranov, K. O., & Бажан, Н. М. (2021) · Cells · doi:10.3390/cells10123440 · Cited by 22
Wang, D., Jiang, D.-M., Yu, R.-R., Zhang, L., Liu, Y.-Z., Chen, J.-X., Chen, H., & Liu, Y. (2022) · Journal of Diabetes Research · doi:10.1155/2022/3780156 · Cited by 24
“Thus, obesity-induced skeletal muscle dysfunction can lead to metabolic disorders, especially insulin resistance [31].”
BackgroundAnsari, P., Hannan, J. M. A., Choudhury, S. T., Islam, S. S., Talukder, A., Seidel, V., & Abdel‐Wahab, Y. H. A. (2022) · Medicines · doi:10.3390/medicines9110056 · Cited by 35
Lu, Y., Lim, W. S., Jin, X., Nyunt, M. S. Z., Fülöp, T., Gao, Q., Lim, S. C., Larbi, A., & Ng, T. P. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.971622 · Cited by 20
“Insulin exerts its anabolic action on skeletal muscles via stimulating glucose disposal (19) and inhibiting protein catabolism (20).”
BackgroundMontgomery, M. K., Bayliss, J. A., Nie, S., Nardo, W. D., Keenan, S. N., Anari, M., Taddese, A. Z., Williamson, N. A., Ooi, G., Brown, W. A., et al. (2022) · Diabetes · doi:10.2337/db22-0590 · Cited by 23
Gayathri, R., Abirami, K., Kalpana, N., Manasa, V. S., Sudha, V., Shobana, S., Jeevan, R. G., Kavitha, V., Parkavi, K., Anjana, R. M., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1055923 · Cited by 24
“Thus, protecting pancreatic β cell function is pivotal for T2D prevention (13).”
BackgroundInfluentialFerdowsi, P. V., Ahuja, K., Beckett, J. M., & Myers, S. (2023) · Molecules · doi:10.3390/molecules28062861 · Cited by 25
“other extracellular stimuli such as muscle contraction and bioactive food components also mediate glucose uptake in skeletal muscle in an insulin-independent manner [28,29,57,58].”
Exosomes as biomarkers and therapy in type 2 diabetes mellitus and associated complications
Satyadev, N., Rivera, M. I., Nikolov, N. K., & Fakoya, A. O. J. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1241096 · Cited by 22
Drp1 controls complex II assembly and skeletal muscle metabolism by Sdhaf2 action on mitochondria
Zhou, Z., Ma, A., Moore, T. M., Wolf, D. M., Yang, N. L., Tran, P. H., Segawa, M., Strumwasser, A. R., Ren, W., Fu, K., et al. (2024) · Science Advances · doi:10.1126/sciadv.adl0389 · Cited by 28
“Skeletal muscle is critical for locomotion and is a primary tissue controlling glucose homeostasis and lipid metabolism in humans and rodents ( 1 , 2 ).”
Anusooriya, P., Deivasigamani, M., Gopalakrishnan, V. K., et al. (2014) · International Scholarly Research Notices · doi:10.1155/2014/130342 · Cited by 20
Nrf2 in Type 2 diabetes and diabetic complications: Yin and Yang
Fu, J., Hou, Y., Xue, P., Wang, H., Xu, Y., Qu, W., Zhang, Q., & Pi, J. (2016) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2016.08.001 · Cited by 22
Role of the Gut on Glucose Homeostasis: Lesson Learned from Metabolic Surgery
Kamvissi, V., Raffaelli, M., Bornstein, S. R., & Mingrone, G. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0642-5 · Cited by 26
Sarr, O., Strohm, R. J., MacDonald, T. L., Gaudio, N., Reed, J., Foute‐Nelong, J., Dyck, D. J., & Mutch, D. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050959 · Cited by 24
“Reduced skeletal muscle glucose uptake due to insulin resistance is the primary defect in type 2 diabetes [3,4].”
BackgroundPrato, S. D., & CHILTON, R. J. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13169 · Cited by 22
“Many other factors (ie, excessive glucagon release, impaired glucagon-like peptide-1 (GLP-1) secretion, augmented renal glucose reabsorption and impaired central nervous system integration) also contribute to the progression of the disease.(2) T2DM, although heralded by hyperglycaemia, is commonly associated with fact…”
BackgroundKido, K., Ato, S., Yokokawa, T., Sato, K., & Fujita, S. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00362.2017 · Cited by 22
“Patients with type 2 diabetes (T2D) develop insulin resistance in several organs, including skeletal muscle, liver, and adipose tissue; this leads to hyperglycemia (10).”
BackgroundShedding Perspective on Extracellular Vesicle Biology in Diabetes and Associated Metabolic Syndromes
Javeed, N. (2019) · Endocrinology · doi:10.1210/en.2018-01010 · Cited by 18
Zou, T., Kang, Y., Wang, B., de Avila, J. M., You, J., Zhu, M. J., & Du, . (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103572 · Cited by 20
Metadata
- Authors
- DeFronzo, R. A., & Tripathy, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Tripathy, Devjit
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S157-S163
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811436
- OpenAlex
- W2170869159
- Cited by
- 2,102
- References
- 115
- Citations by year
- 2026: 149 · 2025: 188 · 2024: 187 · 2023: 161 · 2022: 200 · 2021: 199 · 2020: 161 · 2019: 146 · 2018: 166 · 2017: 132 · 2016: 119 · 2015: 99 · 2014: 72 · 2013: 54 · 2012: 29
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- skeletal muscle insulin resistance, type 2 diabetes, insulin resistance, beta-cell failure, type 2 diabetes pathogenesis, glucose tolerance, hyperglycemia
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Homeostasis, Humans, Insulin, Insulin Resistance, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.